Kymera | Investor Presentation Deck | 60 slides · page 47 of 60
The slide presents clinical trial results for KT-333, comparing degradation percentages across three dose levels (DL1, DL2, DL3) over two cycles.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 list 1/1 table 1/1 title 1/1
Components 4
line bullet data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.